Growth Differentiation Factor-15 Is Not Modified by Sacubitril/Valsartan and Is an Independent Marker of Risk in Patients With Heart Failure and Reduced Ejection Fraction: The PARADIGM-HF Trial

European Journal of Heart Failure - United States
doi 10.1002/ejhf.1301

Related search